Stillbirth Risk Identification Using Multiparametric Ultrasound

NCT06930274 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 282

Last updated 2025-04-16

No results posted yet for this study

Summary

The goal of this observational study is to identify a novel biomarker for stillbirth.

Specifically the aim is to predict perinatal hypoxia using quantitative ultrasound from the placenta (QUS-P) between 35 and 37 weeks gestation.

Conditions

  • Perinatal Hypoxia

Sponsors & Collaborators

  • Wellcome Trust

    collaborator OTHER
  • University of British Columbia

    lead OTHER

Principal Investigators

  • Robert Rohling, PhD · The University of British Columbia

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-03
Primary Completion
2025-07-30
Completion
2025-09-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06930274 on ClinicalTrials.gov